Thanks Hitesh bhai.
I think the key trigger market is waiting for is some US based acquisition from Torrent. Given that they did not repatriate any cash from bumper US sales, and maintaining standalone debt indicates that management is keen on acquisitions.
Also, any inorganic growth would fill up the void from one off abilify sales in FY16. After Cipla and Lupin, Torrent might be next in line.
| Subscribe To Our Free Newsletter |
